As tumour staging may affect the incidence of SETD2 mutations, we performed a chi-squared test to test the difference in tumour staging between SETD2 control and SETD2 case samples, which showed no significant difference (p = 0.373) (Supplementary Fig. 5). Here, SETD2 is linked to neoplasm.